Recent Updates
Recently added Catalysts
PEN

Penumbra, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference in...

Key Takeaway: ALAMEDA, Calif. , Dec. 31, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the 38 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14 , 2020. A webcast of the presentation wi

Full Press Release Details

ALAMEDA, Calif. , Dec. 31, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the 38 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14 , 2020.
Event: 38 th Annual J.P. Morgan Healthcare Conference
Date: Tuesday, January 14, 2020
Time: 5:00pm ET / 2:00pm PT
A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com . The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States , most of Europe , Canada and Australia , and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com .
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
SOURCE Penumbra, Inc.

Related Links

21 %

Last updated: Dec 31, 2019